Ⅰ. Name, Address, and Representative of the Business Handling Personal Information

（Business Name） Ono Pharmaceutical Co., Ltd.
（Address） 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka-shi, Osaka
（Representative） Representative Director, President and CEO, Toichi Takino

Ⅱ. Purposes of Use of Personal Information at the Company

1. Purposes of Use of Personal Information Related to Medical Professionals, Pharmacists, Pharmacies, and Other Healthcare Professionals, as well as Individuals Affiliated with Medical, Pharmaceutical, and Healthcare Research Institutions, and Government Officials of Medical and Pharmaceutical Regulatory
• Provision, collection, and communication of information related to the proper use of products (*1)
• Provision, collection, and communication of information related to the quality, safety, or efficacy of products
• Surveys on product usage, actual usage conditions, user needs, and other related factors, and provision, collection, and analysis of marketing information
• Provision, collection, and communication of information related to proper use of products based on interests and preferences through the analysis of browsing history and other information
• Communication, response, investigation, and reporting in the event of adverse effects, accidents, product recalls, or other related situations regarding products
• Identification of product delivery destinations and establishment of communication networks
• Operations related to survey, research, development, and publication in the fields of medicine, pharmacy, and healthcare
• Support for survey, research, development, and publication in the fields of medicine, pharmacy, and healthcare
• Provision, collection, and examination of medical and academic information
• Operations related to planning, commissioning, and conducting clinical studies, post-marketing surveillance, and other related activities for products (including applications to domestic and foreign regulatory authorities and information sharing with domestic and foreign joint development and partner companies)
• Information disclosure based on our "Guidelines for Transparency in Relationships with Medical Institutions, etc."
• Operations related to the use of information on our website
• Notifications, reports, and other administrative responses to government agencies,organizations the Company participates in, and other related entities
• Building smooth relationships necessary for achieving the purposes of use
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
2. Purposes of Use of Personal Information Related to Patients Who Have Used Pharmaceutical Products (including those who have used them in the past or are planning to use them in the future)
• Provision, collection, and communication of information related to the proper use of pharmaceutical products
• Provision, collection, and communication of information related to the quality, safety, or efficacy of pharmaceutical products
• Surveys on the usage status, actual usage conditions, user needs and other related factors of pharmaceutical products
• Communication, response, investigation, and reporting in the event of adverse effects, accidents, product recalls, or other related situations regarding pharmaceutical products
• Identification of delivery destinations of pharmaceutical products and establishment of communication networks
• Operations related to survey, research, development, and publication in the fields of medicine and pharmacy
• Support for survey, research, development, and publication in the fields of medicine and pharmacy
• Provision, collection, and examination of medical and academic information
• Operations related to planning, commissioning, and conducting clinical studies, post-marketing surveillance, and other related activities for pharmaceutical products (including applications to domestic and foreign regulatory authorities and information sharing with domestic and foreign joint development and partner companies)
• Information disclosure based on our "Initiatives for Transparency in Relationships with Patient Groups"
• Operations related to the use of information on our website
• Notifications, reports, and other administrative responses to government agencies,organizations the Company participates in, and other related entities
• Building smooth relationships necessary for achieving the purposes of use
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
3. Purposes of Use of Personal Information Related to Participants in Clinical Research and Clinical Studies (including those who have participated in the past or are planning to participate in the future)
• Provision, collection, and communication of information related to the proper use of products
• Provision, collection, and communication of information related to the quality, safety, or efficacy of products
• Surveys on product usage, actual usage conditions, user needs and other related factors
• Communication, response, investigation, and reporting in the event of adverse effects, accidents, product recalls, or other related situations regarding products
• Operations related to survey, research, development, and publication in the fields of medicine, pharmacy, and healthcare
• Provision, collection, and examination of medical, healthcare and academic information
• Operations related to planning, commissioning, and conducting clinical studies, post-marketing surveillance, and other related activities of for products (including applications to domestic and foreign regulatory authorities and information sharing with domestic and foreign joint development and partner companies)
• Notifications, reports, and other administrative responses to government agencies, organizations the Company participates in, and other related entities
• Building smooth relationships necessary for achieving the purposes of use
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
4. Purposes of Use of Personal Information Related to Individuals Who Have Used Company Contact Points, such as Public Relations, Product-Related, and Clinical Study-Related Contact Points
• Investigation, review, examination, response, communication, and information provision in response to inquiries, communications, applications, requests received, etc.
• Communication and provision to product manufacturers, sellers, and healthcare professionals, etc.
• Notifications, reports, and other administrative responses to government agencies, organizations the Company participates in, and other related entities
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
5. Purposes of Use of Personal Information Related to Individuals Who Have Used Products Other Than Pharmaceutical Products, or Services Including Apps (including those who have used them in the past or are planning to use them in the future)
• Negotiation and performance of contracts related to products and services (communication of contract details, shipment of products, provision of services, administrative processing such as billing and payment confirmation, etc.)
• Response to inquiries
• Provision of advertisements and information related to products and services based on customer interests and preferences through the analysis of browsing and purchase history, and other information
• Planning, improvement, development, sales, and marketing strategy planning and marketing activities for products and services
• Conducting surveys and analyzing results
• Building smooth relationships necessary for achieving the purposes of use
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
6. Purposes of Use of Personal Information Related to Officers, Directors and Employees of Entities and Individual Business Operators Who Have Business Transactions or Contractual Relationships with the Company (including those in the planning stage of transactions or contracts, and those with past transactions or contracts), such as Pharmaceutical Wholesalers, Contract Manufacturing Organizations, and Contract Research Organizations, etc.
• Communication, negotiation, information provision, examination, outsourcing, provision to a third party, joint use, notifications, reports to government agencies, organizations the Company participates in, and other related entities, and other administrative procedures necessary for transactions related to business purposes stated in our Articles of Incorporation
• Building smooth relationships necessary for achieving the purposes of use
• Outsourcing, provision to a third party, and joint use necessary for achieving the purposes of use
7. *1 "Products" refers to items and services handled in the course of conducting our business.
   
   （Reference: Business Purposes Stated in Our Articles of Incorporation）
• Manufacturing, purchase and sale, or import and export of pharmaceuticals, quasi-drugs, non-medical chemicals, veterinary pharmaceuticals, reagents, diagnostic reagents, reagents for veterinary use, pharmaceutical ingredients, fragrances, cosmetics, foodstuffs, food additives, beverages, agricultural chemicals, fertilizers, feed, feed additives, medical equipment or its materials, measuring devices, other chemical products, and machinery and equipment related to the aforementioned products
• Consignment of pharmaceutical research and development
• Consignment of clinical studies and safety tests
• Management, purchase and sale, and leasing of real estate properties
• Printing and publishing
• Leasing of automobiles and office equipment, and others
• Non-life insurance agency and life insurance solicitation
• Warehousing, freight forwarding, and freight forwarding agency
• Consignment of computer-based data processing and related services
• Temporary personnel placement service
• All other businesses incidental to or relating to the preceding items
8. Purposes of Use of Personal Information Related to Our Shareholders (including those who were shareholders in the past)
• Fulfillment of obligations stipulated by laws and regulations such as the Companies Act and the Financial Instruments and Exchange Act, and rules set by public institutions such as stock exchanges, and response to the exercise of shareholder rights
• Provision of various conveniences from the issuing company to the shareholder's position
• Implementation of various measures to smooth the relationship between the association members and the association
• Notifications, reports, and other administrative procedures based on various laws and regulations
• Outsourcing and provision to a third party necessary for achieving the above purposes of use
9. Purposes of Use of Personal Information Related to Applicants for Selection (Employee Recruitment and Scholarship Recruitment)
• Examination, decision, and implementation of pre-employment procedures, as well as information provision, communication, reporting to alma maters, response to reapplications, and other related operations
• Verification and analysis of recruitment activities, examination and handling of future recruitment activities
• Outsourcing and provision to a third partynecessary for achieving the above purposes of use
10. Purposes of Use of Personal Information Related to Temporary Workers Employed at the Company
• Fulfillment of rights and obligations stipulated in contracts between the Company and temporary employment agencies, such as payment of Remuneration for temporary workers, and related operations
• Outsourcing and provision to a third party necessary for achieving the above purposes of use
11. Purposes of Use of Personal Information Related to Inventors and Patent Holders
• Application, prosecution, and exercise of rights related to inventions, designs, and other intellectual property, and related procedures
• Payment processing for rewards, assignment compensation, royalties, etc., related to inventions
• Notifications and reports to government agencies
• Outsourcing and provision to a third party necessary for achieving the above purposes of use
12. Purposes of Use of Personal Information Related to Officers, Directors, Employees, Seconded Employees to the Company, Former Employees, etc. (including their families)
• Management, procedures, and communication related to employment, work, commendation, and disciplinary actions
• Management, procedures, and communication related to personnel transfers such as assignments within group companies within group companies, personnel evaluations, remuneration, and treatment
• Procedures and communication related to tax matters such as withholding tax
• Management, procedures, and communication related to social and labor insurance, pensions, and welfare benefits
• Ensuring a healthy working environment, fulfilling the duty of care for safety (health) for workers, and fulfilling obligations based on labor agreements
• Planning, management, procedures, and communication related to in-house education, in-house systems, and personnel policies
• Procedures and communication necessary for group companies to conduct business activities legally and appropriately
• Procedures and communication in emergencies
• Other legally required procedures and communication
• Communication and distribution of materials for social activities such as alumni associations
• Outsourcing, provision to a third party and joint use necessary for achieving the above purposes of use
13. To achieve the above paragraph 11 purposes of use, the Company may analyze attendance and usage of business terminals.
    
    The Company will not provide personal data corresponding to the above paragraphs 1 to 11 to a third party except in the following cases:
• Cases in which consent is obtained from the identifiable person
• Cases in which outsourcing is conducted within the scope necessary for achieving the purposes of use
• Cases in which a provision to a third party is made within the scope necessary for achieving the purposes of use with necessary measures based on laws and regulations are taken
• Cases in which joint use is conducted within the scope necessary for achieving the purposes of use
• Cases based on laws and regulations

Ⅲ. Joint Use of Personal Data

The Company will jointly use acquired personal data as follows:

1. Personal Data Held by Nihon Ultmarc Inc. (Medical Database)

①Items of Personal Data for Joint Use	Please refer to Nihon Ultmarc Inc.'s website（https://www.ultmarc.co.jp/privacy/shared_use/index.html）
②Scope of Joint Users
③Purposes of Use by Joint Users
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	Nihon Ultmarc Inc. Please refer to the above website for the address and representative's name.

2. Personal Data Related to External Parties
• Personal Data of Medical Professionals, Pharmacists, Pharmacies, and Other Healthcare Professionals, as well as Individuals Affiliated with Medical, Pharmaceutical, and Healthcare Research Institutions, and Government Officials of Medical and Pharmaceutical Regulatory

①Items of Personal Data for Joint Use	Name, gender, date of birth, age, place of origin, workplace information (facility name, address, phone number, email address, medical department, affiliated department, position/title), graduation year/school, national exam pass year, license number, membership status in academic societies/medical associations, specialist/specialist pharmacist information, prescription-related information, information included in clinical study records, post-marketing surveillance records, and interests and preferences acquired from analyzing browsing history s
②Scope of Joint Users	a. Other companies jointly developing pharmaceutical products b. Other companies jointly selling pharmaceutical products c. Other companies partnering in the development and sale of pharmaceutical products d. The Company's domestic and foreign subsidiaries and affiliates (consolidated entities) For details on companies corresponding to a, b, and c, please refer to the latest "Securities Report" on the Company's website under "Important Contracts in Management."
③Purposes of Use by Joint Users	Purposes stated in paragraph 1 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Personal Data of Patients Who Have Used Pharmaceutical Products (including those who have used them in the past or are planning to use them in the future)

①Items of Personal Data for Joint Use	Adverse effect information, safety information (body, health, medical condition, etc.), and other personal data related to the quality, efficacy, safety, and proper use of pharmaceutical products
②Scope of Joint Users	a. Other companies jointly developing pharmaceutical products b. Other companies jointly selling pharmaceutical products c. Other companies partnering in the development and sale of pharmaceutical products d. The Company's domestic and foreign subsidiaries engaged in the pharmaceutical business
③Purposes of Use by Joint Users	Purposes stated in paragraphs 2 and 4 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Personal Data of Participants in Clinical Research and Clinical Studies (including those who have participated in the past or are planning to participate in the future)

①Items of Personal Data for Joint Use	Research/study data (study subject identification code, measurement results, genetic information, etc.), adverse effect information, safety information (body, health, medical condition, etc.)
②Scope of Joint Users	a. Other companies jointly developing pharmaceutical products b. Other companies jointly selling pharmaceutical products c. Other companies partnering in the development and sale of pharmaceutical products d. The Company's domestic and foreign subsidiaries engaged in the pharmaceutical business e. The Company's domestic and foreign subsidiaries engaged in non-pharmaceutical business
③Purposes of Use by Joint Users	Purposes stated in paragraphs 3 and 4 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Personal Data of Individuals Who Have Used Products Other Than Pharmaceutical Products, or Services Including Apps (including those who have used them in the past or are planning to use them in the future)

①Items of Personal Data for Joint Use	Name, address, age, gender, phone number, email address, browsing history, purchase history, survey responses, content of inquiry, and interests and preferences acquired through the analysis of these information
②Scope of Joint Users	The Company's domestic and foreign group companies selling or providing products other than pharmaceutical products and services including apps
③Purposes of Use by Joint Users	Purposes stated in paragraph 5 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Personal Data of Individuals Who Have Used Company Contact Points, such as Public Relations, Product-Related, and Clinical Study-Related Contact Points

①Items of Personal Data for Joint Use	Name, address, age, gender, phone number, email address, content of inquiry, etc.
②Scope of Joint Users	The Company's domestic and foreign subsidiaries and affiliates (consolidated entities)
③Purposes of Use by Joint Users	Purposes stated in the paragraph 4 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Personal Data of Officers, Directors and Employees of Entities and Individual Business Operators Who Have Business Transactions or Contractual Relationships with the Company (including those in the planning stage of transactions or contracts, and those with past transactions or contracts), such as Pharmaceutical Wholesalers, Contract Manufacturing Organizations, and Contract Research Organizations

①Items of Personal Data for Joint Use	Name, address, workplace information (name, representative's name, address), phone number, email address, affiliation, position/title, etc.
②Scope of Joint Users	The Company's domestic and foreign subsidiaries and affiliates (consolidated entities)
③Purposes of Use by Joint Users	Purposes stated in the paragraph 6 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

3. Personal Data Related to Officers, Directors, Employees, Seconded Employees to the Company, Former Employees, etc. (including their families)
• Joint Use with Affiliated Companies, etc.

①Items of Personal Data for Joint Use	Name, address, phone number, email address, gender, date of birth, and other personnel-related data of officers, directors, employees, and seconded employees (including candidates)
②Scope of Joint Users	The Company's domestic and foreign subsidiaries and affiliates (consolidated entities) ONO Medical Research Foundation Ono Pharmaceutical Foundation for Oncology, Immunology, and Neurology
③Purposes of Use by Joint Users	Purposes stated in the paragraph 11 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Joint Use with Labor Unions

①Items of Personal Data for Joint Use	(i) Employee number, name, and date of occurrence of thereason for leave of union members on leave (ii) Employee number, name, and return date from leave of union members returning from leave (iii) Employee number, name, and retirement date for retired union members (iv) Employee number, name, and departure (return) date of union members assigned to overseas assignments or study abroad
②Scope of Joint Users	Labor union
③Purposes of Use by Joint Users	Salary deduction for union dues
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	The Company

• Joint Use with Corporate Health Insurance Associations

①Items of Personal Data for Joint Use	(i)Name, address, gender, date of birth, family information, qualification acquisition date/loss date, statutory health checkup data/assessment, and other items necessary for insurance benefits and various services provided by health projects for officers, directors, employees, their families, and voluntary continued insured persons (ii)Name, address, phone number, email address, gender, date of birth, and other personnel-related data of officers, directors, employees, and seconded employees (including candidates)
②Scope of Joint Users	Ono Pharmaceutical Corporate Health Insurance Association
③Purposes of Use by Joint Users	(i)Provision of insurance benefits and various services provided by health projects conducted by Ono Pharmaceutical Corporate Health Insurance Association (ii)Purposes stated in paragraph 11 of "II. Purposes of Use of Personal Information at the Company"
④Name, Address, and Representative of the Entity Responsible for Managing Jointly Used Personal Data	(i)Ono Pharmaceutical Corporate Health Insurance Association Address: 2-1-5 Doshomachi, Chuo-ku, Osaka-shi, Osaka Representative: Satoshi Takahagi (ii)The Company

Ⅳ. Provision of Personal Data to Third Parties

1. The Company may provide personal data of individuals engaged in clinical study operations to the following third parties in relation to the purposes of use stated in above II:
• Third parties (companies or individuals) related to planned or ongoing research or joint development partners
• Ethics committees or other regulatory authorities in countries or regions where the Company conducts research and development activities
• Third parties to whom the Company is required to disclose based on legal provisions, legal procedures, court orders, etc.
2. When providing personal data to third parties for the above reasons, the Company may transfer personal data to countries outside Japan. The personal information and personal data protection systems in such foreign countries may not have protection measures equivalent to those in Japan.
3. For products currently under research and development or future research and development products, the countries where research and development will be conducted or the countries of the regulatory authorities to which approval applications will be submitted are undecided, and it is not possible to specify the organizations or countries to which personal data of individuals engaged in clinical study operations will be transferred. Therefore, it is not possible to provide information on the personal information and personal data protection systems or protection measures in such organizations or foreign countries.

Ⅴ. Measures for Managing the Security

The Company implements the following measures for managing the security for personal information:

(Basic Policy Formulation)
To ensure the proper handling of personal information, we have developed the Privacy Policy regarding compliance with the Act on the Protection of Personal Information and other laws and regulations, as well as contact points for inquiries and complaints.

(Development of Rules for Handling Personal Information)
We have developed the Personal Information Protection Policy regarding handling methods, responsible persons, and their duties at each stage of acquiring, using, storing, providing, deleting, and disposing of personal information.

(Organizational Measures for Managing the Security)
We have established a responsible person for handling personal information and a reporting and communication system to the responsible person in case of finding any facts violating the Act on the Protection of Personal Information. Additionally, we conduct regular audits by the audit department regarding the handling status of personal information.

(Personnel Measures for Managing the Security)
We conduct regular training for employees on compliance with the Act on the Protection of Personal Information and other laws. We also include confidentiality obligations of personal information in the work regulations.

(Physical Measures for Managing the Security)
In areas where personal information is handled, we manage employee entry and exit and implement measures to prevent unauthorized persons from viewing personal information. We also take measures to prevent theft or loss of equipment, electronic media, and documents handling personal information.

(Technical Measures for Managing the Security)
We implement access control and introduce systems to protect information systems handling personal information from unauthorized access from outside.

(Understanding External Environments)
When handling personal information in foreign countries, we understand the personal information protection systems in those countries and implement appropriate measures for managing the security .

Ⅵ. Contact Points for Complaints and Requests for Disclosure and Other Handlings

The contact points for complaints, notifications of purposes of use, disclosure, correction, ceasing to use, and ceasing of provision, and other inquiries at the Company are as follows:
[The Company Contact]
Ono Pharmaceutical Co., Ltd. Legal Department (Personal Information Protection Officer)
(Address) 8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka-shi, Osaka 541-8564
(Phone Number) +81-6-6263-5670
(FAX Number) +81-6-6263-2976
(Reception Hours) Monday to Friday 9:00-17:00 JST (excluding holidays, year-end and New Year holidays, and other company holidays)

• *The Company is a target business operator of the Federation of Pharmaceutical Manufacturers' Associations of JAPAN, a certified personal information protection organization recognized by the Minister of Health, Labour and Welfare. The association accepts complaints and consultations regarding the handling of personal information by target business operators.

[Contact Information]
The Federation of Pharmaceutical Manufacturers' Associations of JAPAN "Certified Personal Information Protection Organization Secretariat"
(Address) MFPR Nihonbashi Honcho Building 3F, 3-7-2 Nihonbashi Honcho, Chuo-ku, Tokyo 103-0023
(Phone Number) +81-3-5843-6494
(Reception Hours) Monday to Friday 10:00-16:00 JST (excluding holidays, year-end and New Year holidays, and other designated holidays)

Ⅶ. Response to Requests for Disclosure and Other Handling, and Methods for Receiving Requests

1. Response to Requests for Disclosure and Other Handling
   For requests from identifiable person whose personal information is held by the Company, we will respond as follows:
• Response to requests for disclosure or notification of purposes of use of personal information
  The Company will, without delay,respond to requests for disclosure or notification of purposes of use of personal information from identifiable person after confirming their identity through given procedures. Please note that the personal information subject to disclosure or notification of purposes of use is limited to our "personal data business holds" and its record of provision to a third party . In some cases, we may not be able to accept requests for disclosure or notification of purposes of use based on the Act on the Protection of Personal Information..We appreciate your understanding.
• Response to requests for correction and deletion of personal information
  The Company will, without delay,respond to requests for correction, addition, or deletion (hereinafter referred to as "correction") of personal information from identifiable person after confirming their identity through given procedures. If correction, is not necessary from the perspective of the purposes of use specified by the Company, if the indication of error is incorrect, or if special procedures are stipulated by other laws and regulations, correction will not be made. Please note that the personal information subject to correction is limited to our "personal data business holds."
• Response to requests for ceasing to use, deleting, or ceasing third-party provision of personal information
  The Company will, without delay, respond to requests for ceasing to use, deleting, or ceasing third-party provision of personal information fromidentifiable person after confirming their identity through given procedures. Please note that the personal information subject to ceasing to use, deleting, or ceasing third-party provision is limited to our "personal data business holds." In some cases, we may not be able to accept requests for ceasing to use, deleting, or ceasing third-party provision based on the Act on the Protection of Personal Information. We appreciate your understanding.
2. Methods for Receiving Requests for Disclosure and Other Handling
3. If you wish to make a request for disclosure and other handling as stated in VII-1, please fill in the necessary information on the given document posted at the link at the end of this VII and send them by mail to the Company contact stated in VI. Please note that we do not accept requests by phone, FAX, e-mail, or in-person meetings. We appreciate your understanding.
   Additionally, we will confirm that the request is from the identifiable person or the agent of identifiable person, so please enclose the documents listed in (1) or (2) below. The enclosed documents will not be returned.
   Personal information obtained through the procedures for requests for disclosure and other handling will be used only for procedures related to the request for disclosure and other handling.
   If you are making a request for disclosure or notification of purposes of use, please enclose 500 yen worth of postal stamps as a fee. Response documents will be sent by the method specified by you among the methods listed in the Company's given document (if not specified, by simplified registered mail). If you wish to receive a response by registered mail to be signed by addressee only, please enclose 600 yen worth of postal stamps. (Please note that fees may change without notice, and we appreciate your understanding.)
• Request from identifiable person themselves (please enclose two of the following A to G for identity verification)
  Please mask (black out, etc.) any "Individual Number (My Number)," "Insurer Number," or "Insured Person Symbol/Number" if they are listed on these materials so that they cannot be distinguished .
• Copy of passport
• Copy of driver's license
• Copy of health insurance card
• Copy of pension book
• Original family register or original resident certificate
• Copy of tax certificate (or non-tax certificate)
• Other official documents that can verify the identity of identifiable person
• Request from by an agent (please enclose the following documents)
• Documents verifying the identity of the requester → Same as (1) above
• Documents verifying the identity of the agent → One of A to G in (1) above
• Documents verifying the authority of the agent
• →(Legal representative) Documents verifying legal representation authority (copy of family register, judgment document)
  
• (Voluntary agent) Power of attorney with the requester's registered seal and the requester's seal registration certificate
• *If any of the above documents (including reply stamps for requests for disclosure or notification of purposes of use) are missing or incomplete, the request will not be accepted.
• *We may confirm unclear points regarding the content of the request or the content of the application documents by phone or other appropriate method.
• *There may be cases where we cannot accept requests due to reasons stipulated by law. We appreciate your understanding.

Ⅷ. Handling of Pseudonymized Personal Information

The Company may prepare, acquire, or provide pseudonymized personal information processed so that specific individuals cannot be identified without collating with other information, based on laws and regulations. The purposes of use of prepared or acquired pseudonymized personal information are as follows:

1. Operations related to survey, research, and developmentin the fields of medicine, pharmacy, and healthcare
2. Operations related to planning, commissioning, and conducting clinical trials and post-marketing surveillance, and other related activities for products (including applications to domestic and foreign regulatory authorities and information sharing with domestic and foreign joint development and partner companies)
3. Provision to a third party, outsourcing and joint use necessary for achieving the purposes of use

We will handle pseudonymized personal information appropriately by taking measures for managing the security based on laws and regulations.

Ⅸ. Handling of Anonymized Personal Information

1. The Company may prepare, acquire, or provide anonymized personal information processed so that specific individuals cannot be identified and cannot be restored to the original personal information, based on laws and regulations. The items of personal information included in the prepared or provided anonymized personal information and the methods of providing anonymized personal information are as follows:
2. Items of Personal Information included in the Prepared or Provided Anonymized Personal Information Information related to the body (age (date of birth), gender, height, weight, etc.) Information related to medical treatment and clinical research (disease information, examination information, treatment/procedure information, etc.)
3. Methods of Providing Anonymized Personal Information Sending electronic files protected by password or other means via electronic communication means Sending electronic files protected by password or other means via physical media such as DVDs